Industry expert appointed to support review of Pro-Innovation Regulation of Advanced Manufacturing
Steve Bagshaw has been appointed to support work investigating the pro-innovation regulation of advanced manufacturing, one of the Chancellor’s five key growth areas.
Following announcement at the Autumn Statement, the Government Chief Scientific Adviser is reviewing existing rules and helping develop a pro-innovation regulatory approach that allows the UK to fulfil its ambition to become a science superpower.
The aim of the review is to establish the UK as the best regulated economy in the world in key growth sectors, ensuring that industry and investors have the certainty they need to drive innovation, investment and growth by anticipating new developments in emerging technologies.
In March, Sir Patrick Vallance published reviews on digital technologies and green industries and the government accepted both reports’ recommendations. Having taken up the role of Government Chief Scientific Adviser in April 2023, Professor Dame Angela McLean is continuing this work and published a review on life sciences in May and on the creative industries last week. Again, the government has been pleased to accept all recommendations in each report. Dame Angela will soon publish a report on the Chancellor’s one remaining key growth sector: advanced manufacturing.
Steve Bagshaw has been appointed to support Professor Dame Angela on this final report, working directly with industry to identify barriers to innovation and regulatory reforms that can help make the UK’s advanced manufacturing industries the most exciting and enterprising in the world.
Steve Bagshaw is Non-Executive Director at the CPI, former CEO of Fujifilm Diosynth Biotechnologies, and former manufacturing advisor to the Vaccines Taskforce. He is a member of the UKRI Biotechnology and Biological Sciences Research Council. He chaired the UK’s Industrial Biotechnology Leadership Forum from 2013 to 2021 and was co-chair of the UK Bioeconomy Strategy Board between 2016 and 2021. Steve was awarded a CBE in January 2021 for his services to manufacturing and biotechnology.